Percutaneously administration preparation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/14 (2006.01) A61K 9/06 (2006.01) A61K 9/70 (2006.01) A61K 31/473 (2006.01) A61K 47/12 (2006.01)

Patent

CA 2203566

A transdermal administration preparation containing a 9-aminocyclopenta(b)quinoline, preferably 9-amino- 2,3,5,6,7,8-hexahydro-1H-cyclopentane(b)quinoline or its hydrochloride, as an active ingredient and the following transdermal absorption enhancer, that is, at least one compound selected from the group consisting of fatty acids, fatty acid esters, and alcohols, preferably the glyceride of a saturated fatty acid having 6 to 12 carbon atoms.

Cette préparation administrable par voie percutanée contient une 9-aminocyclopenta(b)quinoline, de préférence 9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline ou un hydrochlorure de cette quinoline, comme principe actif, ainsi qu'au moins un accélérateur d'absorption percutanée, choisi dans le groupe constitué par des acides gras, des esters d'acides gras et des alcools, tels que de préférence un glycéride d'un acide gras saturé en C6-C12.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Percutaneously administration preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Percutaneously administration preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Percutaneously administration preparation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2018715

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.